Cho Kyu Suk, Lee Eun Joo, Kim Jung Nam, Choi Ji Woong, Kim Hahn Young, Han Seol-Heui, Ryu Jong Hoon, Cheong Jae Hoon, Shin Chan Young, Kwon Kyoung Ja
Department of Neuroscience, Center for Neuroscience Research, Institute of Biomedical Science and Technology, Konkuk University School of Medicine, 120 Neungdong-ro, Gwangjin-gu, Seoul, 143-701, Korea.
Department of Pharmacology, College of Pharmacy, Gachon University, Incheon, Korea.
Neurochem Res. 2015 Nov;40(11):2242-51. doi: 10.1007/s11064-015-1714-y. Epub 2015 Sep 8.
Proteinase 3 (PR3) is released from neutrophil granules and is involved in the inflammatory process. PR3 is implicated in antimicrobial defense and cell death, but the exact role of PR3 in the brain is less defined. Microglia is the major immune effector cells in the CNS and is activated by brain injury. In the present study, the effect of PR3 on glial activation was investigated. Microglial activation was assessed by the intracellular level of reactive oxygen species and expression of inflammatory cytokines. The conditioned media from activated microglia by PR3 was used for measuring the neurotoxic effects of PR3-stimulated microglia. The effects of PR3 in vivo were measured by microinjecting PR3 into the rat brain. Herein we show that PR3 increased the inflammatory responses including the intracellular ROS and pro-inflammatory cytokine production in rat primary microglia. Conditioned media from PR3-treated microglia induced neuronal cell death in a concentration dependent manner. Furthermore, microinjected PR3 into the striatum of the rat brain induced microglial activation and neuronal cell death. Interestingly treatment with anti-PR3 monoclonal antibody and protease inhibitors ameliorated microglial activation induced by PR3 in primary microglia and striatum, which also prevented neuronal cell death in both conditions. The data presented here suggest that PR3 is a direct modulator of microglial activation and causes neuronal death through the augmentation of inflammatory responses. We suggest that PR3 could be a new modulator of neuroinflammation, and blocking PR3 would be a promising novel therapeutic target for neuroinflammatory disease such as stroke and Alzheimer's disease.
蛋白酶3(PR3)从中性粒细胞颗粒中释放出来,并参与炎症过程。PR3与抗菌防御和细胞死亡有关,但PR3在大脑中的具体作用尚不清楚。小胶质细胞是中枢神经系统中的主要免疫效应细胞,可被脑损伤激活。在本研究中,研究了PR3对胶质细胞激活的影响。通过细胞内活性氧水平和炎性细胞因子的表达来评估小胶质细胞的激活。用PR3激活的小胶质细胞的条件培养基来测量PR3刺激的小胶质细胞的神经毒性作用。通过将PR3微量注射到大鼠脑中测量其在体内的作用。在此我们表明,PR3增加了大鼠原代小胶质细胞中的炎症反应,包括细胞内活性氧和促炎细胞因子的产生。PR3处理的小胶质细胞的条件培养基以浓度依赖的方式诱导神经元细胞死亡。此外,将PR3微量注射到大鼠脑纹状体中可诱导小胶质细胞激活和神经元细胞死亡。有趣的是,用抗PR3单克隆抗体和蛋白酶抑制剂处理可改善原代小胶质细胞和纹状体中PR3诱导的小胶质细胞激活,这也可在两种情况下预防神经元细胞死亡。此处呈现的数据表明,PR3是小胶质细胞激活的直接调节因子,并通过增强炎症反应导致神经元死亡。我们认为PR3可能是神经炎症的新调节因子,阻断PR3将是中风和阿尔茨海默病等神经炎症性疾病有前景的新型治疗靶点。